SAI LIFE SCIENCES LTD
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was … Read more
SAI LIFE SCIENCES LTD (SAILIFE) - Total Assets
Latest total assets as of September 2025: ₹33.32 Billion INR
Based on the latest financial reports, SAI LIFE SCIENCES LTD (SAILIFE) holds total assets worth ₹33.32 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SAI LIFE SCIENCES LTD - Total Assets Trend (2022–2025)
This chart illustrates how SAI LIFE SCIENCES LTD’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
SAI LIFE SCIENCES LTD - Asset Composition Analysis
Current Asset Composition (March 2025)
SAI LIFE SCIENCES LTD's total assets of ₹33.32 Billion consist of 47.6% current assets and 52.4% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 2.9% |
| Accounts Receivable | ₹7.87 Billion | 24.9% |
| Inventory | ₹1.19 Billion | 3.8% |
| Property, Plant & Equipment | ₹0.00 | 0.0% |
| Intangible Assets | ₹108.56 Million | 0.3% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2022–2025)
This chart illustrates how SAI LIFE SCIENCES LTD's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SAI LIFE SCIENCES LTD's current assets represent 47.6% of total assets in 2025, an increase from 43.7% in 2022.
- Cash Position: Cash and equivalents constituted 2.9% of total assets in 2025, down from 5.4% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 24.9% of total assets.
SAI LIFE SCIENCES LTD Competitors by Total Assets
Key competitors of SAI LIFE SCIENCES LTD based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
SAI LIFE SCIENCES LTD - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - SAI LIFE SCIENCES LTD generates 0.54x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, SAI LIFE SCIENCES LTD generates $5.38 in net profit.
SAI LIFE SCIENCES LTD - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.92 | 1.22 | 1.28 |
| Quick Ratio | 1.76 | 1.10 | 1.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹7.14 Billion | ₹ 1.88 Billion | ₹ 2.05 Billion |
SAI LIFE SCIENCES LTD - Advanced Valuation Insights
This section examines the relationship between SAI LIFE SCIENCES LTD's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.49 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 38.9% |
| Total Assets | ₹31.60 Billion |
| Market Capitalization | $1.01 Billion USD |
Valuation Analysis
Below Book Valuation: The market values SAI LIFE SCIENCES LTD's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: SAI LIFE SCIENCES LTD's assets grew by 38.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SAI LIFE SCIENCES LTD (2022–2025)
The table below shows the annual total assets of SAI LIFE SCIENCES LTD from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹31.60 Billion | +38.89% |
| 2024-03-31 | ₹22.75 Billion | +4.05% |
| 2023-03-31 | ₹21.87 Billion | +1.04% |
| 2022-03-31 | ₹21.64 Billion | -- |